Provider’s Clinical Support System – Medication Assisted Treatment Grant
Grant Opportunity Analysis
The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Provider’s Clinical Support System – Medication Assisted Treatment Grant." This grant aims to expand training for primary care providers in the evidence-based prevention and treatment of opioid use disorders (OUD) and chronic pain, with a focus on increasing access to medication-assisted treatment (MAT) through the prescribing of FDA-approved medications. The program is particularly significant as it addresses the critical need for enhanced training and understanding of MAT in combating the opioid crisis. The estimated total program funding is $2,000,000, with one award expected. Interested applicants, specifically national professional medical organizations authorized by the Drug Addiction Treatment Act of 2000, can reach out to Humberto Carvalho at Humberto.Carvalho@samhsa.hhs.gov or (240) 276-2974 for further information.
Eligible Applicants
Eligibility is limited to the national professional medical organizations authorized by the Drug Addiction Treatment Act of 2000 (DATA) to carry out the training of providers desiring to prescribe and/or dispense FDA-approved schedule III medications for the addictive disorders. These are the American Society of Addiction Medicine (ASAM), the American Academy of Addiction Psychiatry (AAAP), the American Medical Association (AMA), the American Osteopathic Academy of Addiction Medicine (AOAAM), and the American Psychiatric Association (APA).
Grant Documents
No documents available for this grant.